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Introduction
The commercialisation of scientific and technological knowledge is 
crucial to economic growth and development (Fontes, 2005; Ndon-
zuau et al., 2002). Within a knowledge based economy, the universi-
ty becomes a component of the innovation system where academic 
technology transfer can occur through several mechanisms such as 
licensing, publication, cooperative research and development agree-
ments and spinoff formation (Iacobucci and Micozzi, 2014; Rogers 
et al., 2001). Fontes (2005) describes technology transfer as a process 
comprising the development of applications for new scientific con-
cepts and turning these into viable technologies, products or services. 
Rogers et al. (2001) considers technology transfer to be an informa-
tion transformation process where information is moved from a re-
search and development organisation to a receptor organisation such 
as a private company. Siegel et al. (2004) investigate the process within 
an academic setting and defined it in terms of a linear flow model be-
ginning with a discovery by a university scientist through to its paten-
ting and licensing to an existing firm or start-up. However, Rogers et 
al. (2001) argues that such a linear model of the process may not fully 
account for external environmental factors such as market demands 
and regulatory factors.  
Spinoffs are identified as a particularly effective means of technolo-
gy transfer (Rasmussen and Borch, 2010). Researchers have found 
that they are an important mechanism for the commercialization of 
research results (Rasmussen and Borch, 2010; Lee, 2001) leading to 
both job and wealth creation (Rogers et al., 2001; Ndonzuau et al., 
2002, Pérez and Sánchez, 2003). Moreover, many researchers have 
found that spinoffs have a positive effect on the local economy (Ia-
cobucci and Micozzi, 2014; Vincett, 2010; Pérez and Sánchez, 2003). 
Wennberg et al. (2001) define two discrete spinoff routes: spinoff 
firms that emerge directly from universities, university spinoffs 
(USOs), and firms that are spun out by university-educated founders 
who pursue careers in private industry and subsequently spinoff from 
this commercial setting, corporate spinoffs (CSOs). It should be no-
ted, however, that whilst an effective means of technology transfer 
spin-off creation is also “the most complex way of commercializing 
academic research” (Iacobucci and Micozzi, 2014). Compared with 
other technology transfer mechanisms, it is risky and fraught with 
challenges. Furthermore, there is no guarantee of success. Indeed, re-
search suggests that spinoff ventures emerging from incumbent firms 
within a specific industry are more likely to commercialise a product 
than other entrants, such as those emerging from academia (Curran 
et al., 2011; Wennberg et al., 2001). This is largely attributed to the fact 
that ventures emerging from incumbent firms inherit sector specific 
knowledge, something which ventures emerging from academic bac-
kgrounds largely lack.  
While there are many factors that impede technology transfer and 
market entry (Pérez and Sánchez, 2003; Van Dierdonck and Debac-
kere, 1988), D’este et al. (2012) highlights the importance of non-
financial factors such as market focus, knowledge management and 
regulation. Indeed, these factors may be more pertinent to specific 
technologies or industries. For example, regulatory knowledge has 
been identified as a key knowledge deficit for academics entering 
the medical device industry (Curran et al., 2011; Chatterji, 2009; van 
Egeraat et al., 2009; Regnstrom et al., 2010). Academic research must 
cross the regulatory ‘chasm’ whilst navigating a multitude of regula-
tory routes and permutations. This market entry barrier may, poten-
tially, be a causative factor for the low incidence and success of spinoff 
formation.
To investigate this further, this study sought to analyse the academic 
medical device spinoff formation process through a regulatory lens. 
We advocate that in order to understand what drives behaviours in 
specific contexts, distinctive factors (such as processes and practices) 
pertaining to pertinent issues (such as regulation activities) must 
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be explored and analysed in more detail. While this perspective has 
emerged in many areas in management research, the underlying mi-
crofoundations of these concepts have not received adequate atten-
tion in the literature (see Argote and Ren, 2012; Abell et al., 2008; 
Felin and Foss, 2005) and authors such as Felin et al (2012) are calling 
for more studies in this space.  Accordingly, in an attempt to address 
this deficit, this study adopts a microfoundations lens to capture em-
pirical data in a specific real-world context. 
Three groups namely; academic researchers; facilitators of the spinoff 
process (such as funding agencies, technology transfer offices and 
investors); and existing spin off companies, working in the medical 
device industry in Ireland are examined. Our research explores the 
perceived level of importance of medical device regulations as well as 
the level of regulatory knowledge in the sample. We then investigate 
the spin off formation process in more detail and ascertain when re-
gulatory issues are first considered. We asked participants in our stu-
dy to rate the criticality of activities that support spin off formation; 
to determine the barriers to spin off formation and to determine the 
key factors that influence spin off success and survival. Findings from 
this analysis are reported and discussed.
The remainder of the paper proceeds as follows. We begin with a 
synthesis of the extant literature in the area of academic spinoffs to 
understand the concepts, issues and themes. Next, we provide a sum-
mary of the research methods employed in this study. Thereafter we 
present the findings of our study and discuss these findings relative to 
the pertinent literature. 
Understanding university spinoffs
The knowledge spillover theory of entrepreneurship emphasises 
the importance of university spinoffs as a mechanism for exploiting 
knowledge and scientific discoveries created by academic researchers 
(Carree et al 2014; Audretsch and Lehmann, 2005). According to 
Uctu and Jafta (2012) there is no universally accepted definition of 
university spinouts in the literature. They are sometimes referred to as 
academic spin-offs (Ndonzuau et al., 2002), and spin-outs (Smilor et 
al., 1990). Link and Scott (2005) contend that university spinoffs are 
“extraordinarily heterogeneous” and so it is difficult to generalise the 
research findings. However, there is general consensus regarding two 
key elements, namely the status of the founder and the nature of the 
knowledge transferred. Simply put, the founder of an academic spin-
off is or was affiliated to a university and the knowledge or invention 
was originally developed within a university (O’Shea et al., 2008; Link 
and Scott, 2005; Nicolaou and Birley 2003a; Smilor et al., 1990).
Pérez and Sánchez, 2003 assert that spinoffs transfer technology in 
two ways; (a) they transfer the technology from the parent organiza-
tion to the new business entity and (b) they transfer the technology 
to the market. In an attempt to better understand the types of spinoffs 
Wright et al., (2006) have classified them along three dimensions the 
‘Venture Capital backed’ type, the ‘prospector’ type and the ‘lifestyle’ 
type.  
A detailed synthesis of the literature reveals that much work has been 
conducted in the space. The extant literature comprises studies from 
many different thematic areas ranging from motivation and persona-
lity characteristics of the founder and the team, to the spinoff process 
and the role of support organisations. Table 1 presents an overview of 
the type of academic studies that have been conducted in the area of 
University spinoff formation.
Table 1.  Synthesis of relevant studies
Research theme Reference 
Academic motivation to 
spinoff  
Fini et al., 2008; Henrekson and Rosenberg, 
2001; D’Este and Perkmann, 2010; Louis et al., 
2001
Characteristics of the 
spinoff founder
Rosa and Dawson, 2006; Grandi and Grimaldi, 
2005; Klofsten and Jones-Evans, 2000 
Characteristics of the 
spinoff team 
Knockaert et al., 2011; Vanaelst et al., 2006; 
Heirman and Clarysse, 2007; Clarysse and 
Moray, 2004; Grandi and Grimaldi, 2003
Characteristics of the 
spinoff organisation
Iacobucci et al. 2011; Niosi 2006; Vanaelst et al. 
2006; Vohora et al. 2004
The spin off process
Harrison and Leitch, 2010; Poon and Liyanage 
2004 Ndonzuau et al 2002; Bower 2003
The role of the parent 
organisation
Rasmussen and Borch, 2010; Harrison and 
Leitch, 2010; Lockett and Wright, 2005; 
Franklin, et al 2001; Bray and Lee, 2000, Rap-
pert and Webster, 1997, Rogers et al., 2001 
The role of technology 
transfer offices
Algieri et al. 2011; Mustar et al 2008; Siegel et 
al 2007; Lockett et al. 2005; Sharif and Baark, 
2008
Role of partners and 
advisors 
Walter et al, 2006; Mosey and Wright, 2007; 
Hoang and Antoncic, 2003; Perez and Sánchez 
2003; Nicolaou and Birley, 2003a,b; Phan et al. 
2005; Siegel et al., 2003d
While these studies have contributed significantly to advance our un-
derstanding of the concept of the academic spinoff there is a dearth of 
focused empirical data on specific real-world contexts. More specifi-
cally, explicit underlying factors that are essential to the spinoff pro-
cess in particular industries require further attention. For example, 
regulatory factors have been found to have a significant influence on 
the performance of the medical device industry. Blind (2012) argues 
that regulations increase the hurdles and consequently the complian-
ce costs, which companies must overcome to enter a specific market. 
Moreover Curran et al. (2011) identified knowledge about regulatory 
procedures as a critical competency required in the early stages of a 
university spinoff. Despite this, little progress has been made to advan-
ce our knowledge in this domain, Few, if any, studies have specifically 
looked at the impact of medical device regulatory requirements on the 
academic spinoff process. This study attempts to bridge this gap.
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Research Methodology 
Case study analysis was used to determine the relationship between 
regulatory knowledge and the academic spinoff formation process. 
The reasons for this are as follows;
• The research undertaken in this study is considered explo-
ratory in nature, as relevant variables have yet to be defined. 
• The exact subject under investigation is not very well docu-
mented in the literature; therefore, the research could not be 
conducted experimentally.
• The study investigates complex issues and processes and hen-
ce the researcher anticipated that as the research proceeded 
the issues were likely to unfold to reveal new dimensions. 
• A substantial amount of research was concerned with co-
llecting and assessing the views and opinions of participants.
Care was taken to ensure rigour and objectivity in the study. Evidence 
was collected from multiple sources and triangulated. A purposive, 
non-probability stratified sample was identified. A non-probability 
sample is effective when, as in this study, the research is exploring 
what is occurring. Sample selection was dictated by analytical (rather 
than statistical) generalisation and replication in accordance with 
best practice. Samples were carefully selected so that they matched 
the purpose of the study i.e. structural representation (Voss et al., 
2002; Yin, 2014). In total 91 organisations were initially contacted. 
The sample comprised three cohorts. Group I contained academic 
researchers, Group II included facilitators of the spinoff process and 
Group III was made up of founders of medical device spinoff compa-
nies (see table 2). Each potential participant was sent a personalised 
pre-notification invitation outlining the supporting background in-
formation, purpose and use of the study as recommended by Fan and 
Yan, 2010 and Sanchez-Fernandez et al., 2012. 
Structured templates were used to help organise and capture the data 
(Kvale and Brinkmann, 2009). The data collection instrument was 
pilot tested prior to distribution (Panacek, 2008) and modified to en-
sure that the correct information was gathered. Data was coded and 
analysed following best practice protocols. Themes were advanced, 
and propositions were compared to the extant literature. This helped 
to strengthen internal validity and reliability.
Table 2. Sample size metrics
Group Invited Questionnaire sent (n)
Questionnaire 
received (n) Response (%)
Group I 20 13 12 92.3
Group II 62 34 15 44.1
Group III 9 8 7 87.5
Total 91 55 34 61.8
Findings 
Overall, 34 responses were received out of a total sample size of 55 
resulting in a relatively high response rate of 61.8% (Sauermann and 
Roach, 2012).  Group I achieved the highest overall response rate of 
92.3%, closely followed by Group III at 87.5%. Group II resulted in 
the lowest response rate of 44.1%. Group I predominately consisted 
of principal investigators, postdoctoral and postgraduate academics. 
Most respondents in Group II comprised technology transfer office 
staff. Other participants included research funding agencies and ven-
ture capital firms. In relation to Group III, all respondents were deri-
ved from spin-off medical device organisations. Of the 7 respondents, 
4 were previously employed in academia and 3 in a medical device 
firm prior to the spinoff formation. A 100% retention rate was achie-
ved for survey Groups I and III with 85% achieved for Group III. As a 
result, an overall retention rate of 93% was achieved.
Regulatory knowledge and awareness
Less than half of all respondents deemed medical device regulations 
to be critical while many considered them to be very important. Res-
pondents in Group I stated that the principle reason for attributing 
a high level of importance to regulatory requirements was to enable 
academic research to be taken seriously within the medical device in-
dustry. Similarly, respondents from Group II considered due diligen-
ce, in terms of regulatory requirements and strategies, as key factors. 
Respondents from Group III also noted that regulatory strategies and 
intellectual property protection were critical for securing investment.
The majority (75%) of Group I rated their regulatory knowledge as 
between fair and good with less than half indicating that they have 
had prior experience in medical device regulations.  However, only 
2 respondents considered their knowledge to be very good. 60% of 
Group III rated their regulatory knowledge as poor at the time of 
spinoff formation. No one, from either group, considered their level 
of regulatory knowledge to be excellent.
Interestingly the majority of respondents from Group III initially 
outsourced regulatory affairs when spinning off their respective orga-
nisations. As the organisations have matured, only 1 spinoff remains 
fully reliant on outsourced regulatory expertise. The remainder have 
either fully developed in-house regulatory expertise or take a blended 
approach using both in-house and third party expertise. The latter 
case appears to be particularly relevant when entering markets with 
differing regulatory frameworks. 
Regulatory considerations in the spin off process 
Respondents were asked when they incorporate regulatory require-
ments and strategies in academic research. 62.5% of respondents in 
Group I incorporate regulatory requirements and strategies as part 
of their research proposals and grant applications with 68.8% con-
tinuing their incorporation when undertaking pre-clinical research 
activities. These requirements and strategies are predominantly 
identified by the researchers themselves with approximately 70% of 
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researchers attesting to doing so. Those who do not take regulatory 
considerations into account indicate that the reasoning for this relates 
to the type of research being conducted, i.e. Proof-of-Principle (PoP) 
or Proof-of-Concept (PoC) studies and blue sky research.
82.4% of respondents in Group II review regulatory strategies as part 
of their assessments with 76% considering them to be either very im-
portant or critical.  All 7 respondents within Group III incorporated 
regulatory strategies within their business plans.
Actors in Groups I and III were asked to identify at what stage in the 
process is (Group I), or was (Group III), commercialisation of their 
research first considered. Three quarters of actors in Group I state that 
commercialisation is first considered in the early stages of the process 
between project proposal and early stage research, with the majority 
considering it at the project proposal stage. This trend is not, however, 
mirrored by actors in Group III, with 100% indicating early to late sta-
ge research as when commercialisation was first considered, with the 
majority (57.1%) indicating early stage research as the relevant stage.
Figure 1. Stage at which commercialisation of academic research is first considered
Participants across all three actor groups were asked to indicate at 
what stage regulatory considerations should begin to be considered 
when academic research is being undertaken.  Over half of respon-
dents in Groups II and III believe they should be considered in the 
first stage, funding application, whilst only 25% of Group I have the 
same opinion. There is, however, an overall trend indicating that re-
gulatory requirements require consideration in the earlier rather than 
later stages of the process.
The actors within Group III were investigated further to ascertain 
whether the process stage at which they indicated regulations should 
be first considered matched that at which they were in practice. Whilst 
58% of these respondents consider the funding application stage to be 
the most relevant one at which regulatory requirements should be consi-
dered, none however implemented this in practice. 58% of respondents 
indicated that regulatory requirements were first considered in the latter 
stages of the process; those of seeking investment and spinoff formation.
Figure 2. Actual versus suggested stage at which regulatory requirements are considered during the spinoff formation process
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Supports to spin off formation
All three actor groups were asked to rate the criticality of the activities 
which support spinoff formation e.g.  funding, due diligence, com-
mercial assessment, technical assessment and regulatory assessment. 
Respectively, 62.5% and 68.75% of respondents within Group I dee-
med funding and due diligence to be critical in supporting spinoff 
formation. Commercial, technical and regulatory assessments were 
largely regarded as having the same level of criticality.
Within Group II, funding, due diligence and commercial and tech-
nical assessments were broadly considered as having equal weight. 
Overall, commercial assessment was considered as most important 
with 82.4% of respondents deeming it to be critical. Regulatory assessment 
was considered as being critical by just 47.1% of respondents in this group.
Funding was considered the most important factor in supporting 
spinoff formation by respondents in Group III with 85.7% viewing 
it as being critical. The levels of importance attributed to due di-
ligence, and technical and regulatory assessments were equally 
distributed at 57.1% critical, 28.6% very important and 14.3% im-
portant.
Participants were asked to rank four categories of barriers to spinoff 
formation namely
1. Cost factors (i.e. financing)
2. Knowledge factors (i.e. Acquiring the appropriate staff)
3. Market factors, (i.e. Competition and customer demand)
4. Regulatory factors (i.e. Meeting requirements).
Four weighted ranking levels were provided: low (1), medium (2), 
high (3) and highest (4). The average ranking for each barrier is pre-
sented in Figure 3.
Figure 3. Average ranking of barriers to spinoff formation
Across all three groups cost factors were considered as being the 
highest barrier to spinoff formation with average weighted rankings 
of between 2.82 and 3. Respondents in Group III attributed the hig-
hest average weighted ranking (3) to this factor. Regulatory factors 
were considered as being second to cost factors by Groups I and III 
followed by knowledge and market factors which were broadly at-
tributed the same average weighted ranking. The opposite trend was 
observed in responses received from Group II; knowledge and market 
factors were equally placed second at 2.47 followed by regulatory fac-
tors with a value of 2.24.
To investigate what influences a spinoff ’s success and survival all 
three groups were asked to rate the relative importance of five 
factors: funding, intellectual property (IP) protection, market analy-
sis, research and development, and regulatory strategy. All three 
groups considered continued funding to be the most critical factor 
to ensure success and survival. Equally, both IP protection and re-
gulatory strategy were considered second to continued funding by 
actors in Group I with 32.5% of respondents considering such factors 
to be critical. At 42.9%, a similar trend is seen in Group III with the 
addition of market analysis and awareness. Group II, however, pla-
ces more importance on market awareness with 58.8% considering 
it to be critical.  Continued research and development is considered 
critical by only 18.75%, 17.6% and 14.3% of respondents in Group 
I, II and III respectively. It is, however, acknowledged as being very 
important across all three groups.
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Influence of early incorporation of regulations
The opinions of actors in Groups II and III were sought on how the 
early identification of regulatory requirements by researchers and the 
incorporation of regulatory strategies within academic research could 
improve the spinoff formation process. There is strong agreement bet-
ween Groups II (70.6%) and III (71.4%) that incorporating regulatory 
strategies within funding proposals would enhance both the applica-
tion process and evaluation process.
There is further strong agreement between the groups with approxi-
mately 70% of both groups considering regulatory strategies would 
enhance business plans when embarking on the spinoff process. Re-
garding capital investment applications and reviews, and how the in-
corporation of regulatory strategies could enhance the process, the 
opinions of both groups mirror each other However, in both cases 
there is not as strong an agreement as previously seen, with approxi-
mately 55% strongly agreeing and 42% agreeing.
There is diverging opinion as to whether the early identification of re-
gulatory requirements and strategies would reduce spinoff costs and 
time to market. 71.4% of respondents in Group III strongly believe 
cost and time to market could be reduced but only 35.3% of Group 
II has the same opinion. 5.9% of Group II disagree, primarily as they 
believe that by identifying such requirements both cost and time may 
be increased to enable such requirements to be met. This, however, is 
countered by the agreement of those who agree; whilst initially both 
costs and time may increase it acts to reduce errors which, if realised 
at a later stage, could significantly increase both costs and time, parti-
cularly in the case of innovative technologies.
Discussion 
Regulatory knowledge and awareness
Results reveal that 87% of respondents from Groups I and III rate 
the importance of medical device regulations as being either very im-
portant or critical, particularly in the case of applied research. This 
is reflected in the finding that over 60% of Group I incorporate re-
gulations within both funding applications (25%) and pre-clinical 
research activities (38%) whilst all responses received from Group 
III indicated that regulatory requirements were incorporated within 
their business plans. However, 65% of these respondents rated their 
regulatory knowledge as between poor and fair. Furthermore, 82% of 
those who review research for the purposes of funding, patenting or 
investment (i.e. Group II) also review the associated regulatory stra-
tegies with 76% considering them to be a very important or critical 
component of the research.
There is an apparent inequality between regulatory awareness, or 
perceived importance, and knowledge. This inference is supported 
by those who found that spinoffs who inherit non-technical comple-
mentary knowledge, such as regulatory knowledge, are more likely to 
successfully commercialise a medical device and that a lack of such 
knowledge may be an important contributory factor to low incidence 
of spinoff formations (Curran et al., 2011, Chatterji, 2009 and van 
Egeraat et al. 2009). It has been previously identified that spinoffs 
who emerge from corporate parents are more liable to inherit this 
knowledge than academic spinoffs (Wennberg et al., 2001); this is also 
reflected in the findings of the survey which reveal that, whilst appro-
ximately half of the actors in Group I indicate having prior regulatory 
experience; the majority has been gained through academic pursuits 
such as workshops etc. Of the 7 responses received from academic 
spinoffs, over 70% relied on outsourced regulatory expertise.
Regulatory considerations in the spin off process
A disparity between the stage at which commercialisation of research 
and the stage at which regulatory requirements are first considered is 
evident where just under half of Group I respondents stated that com-
mercialisation decisions are made at the project proposal or funding 
application stage. Comparatively, only 25% considered that regula-
tory requirements should be considered at the same stage. This gap 
is further exacerbated when the responses of Group III are reviewed. 
Whilst commercialisation decisions were made at a later stage to that 
indicated by Group I, regulatory considerations were also conside-
red at a much later stages of the spinoff process; 58% of respondents 
indicated that they were only considered when seeking investment 
or at the time of actual spinoff. This finding mirrors that found by 
the European Medicines Agency’s SME Office who found that SMEs 
also tend to seek their advice at the later stages of the development 
process.
This observation appears to contradict the finding that over 60% of 
Group I incorporate regulations within both funding applications 
and pre-clinical research activities. The reason for this contradiction 
is not immediately evident. Perhaps, the level of initial regulatory 
consideration is minimal with the burden of regulatory compliance 
only becoming evident at later stages. Interestingly, 58% of actors in 
Group III would now first consider the identification of regulatory 
requirements at the earliest stage.
Responses from Group II also indicated that regulations should be 
considered sooner rather than later with 53% indicating funding 
application as the most appropriate stage. A strong case can be made 
for the earlier consideration of regulations for applied research, whe-
reas the commercial viability of, and hence the need to consider re-
gulatory requirements for, exploratory research may only become 
apparent at a later stage. What we may deduce from these findings is 
that, although regulations are considered they may only be accurately 
considered during the later stages of the commercialisation process. 
A theoretical explanation of this, based on skill complementarities 
which are required for entrepreneurs, is proposed by Lazear (2004). 
This theory recognises that entrepreneurs must have knowledge of a 
wide variety of business areas and skill complementarities. Empirical 
evidence suggests academics with a balanced skill profile experien-
ced shorter time-lags in spinoff formation than academics with an 
unbalanced skill profile. An unbalanced skill profile may be consi-
dered as a barrier to spinoff formation, more specifically, a revealed 
barrier which is defined as barriers which emerge due to the direct 
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experience in the engagement of innovation activities resulting in the 
awareness of the associated difficulties (D’este et al., 2012). Regula-
tory knowledge may be considered as a revealed barrier with poten-
tial to delay spinoff formation; this is perhaps reflected in the shift in 
the opinions of Group III respondents as to when regulatory factors 
should first be considered.
In order to overcome these barriers Muller (2010) suggests that mat-
ching spinoff founders with complementary skill profiles should be 
taken into account when designing policy measures to foster spinoff 
creation such as supporting and assisting founders.
Supports to spin off formation
As expected, funding is largely considered as the most critical aspect 
across all three survey groups for both enabling spinoff formation and 
supporting its success and survival. However, regulatory assessment 
is ranked as one of the least critical factors in supporting spinoff for-
mation. It could be argued that this is due to the formation of a spinoff 
company not being dependent on complying with medical device re-
gulations. It is this market activity which is ultimately critical to the 
success and survival of the company, an argument supported, to a cer-
tain degree, by the relative increase in the percentage of respondents 
who rank regulatory assessment as being critical in supporting suc-
cess and survival; regulatory assessment moves from being one of the 
least critical factors for spinoff formation to being rated on par with 
intellectual property/due diligence factors in terms of success and 
survival by actors in Groups I and III. Safeguarding and marketing 
the universities intellectual property is the technology transfer office’s 
primary motive whist commercialising university-based research for 
financial return is that of investors (Siegel et al., 2004). 
Regulatory requirements have a direct relationship with funding re-
quirements, in terms of both initial and continued funding but differ 
across the different medical device classifications which, in turn, he-
avily influences the costs associated with ensuring compliance. The 
weighting attributed to criticality of regulatory factors is perhaps un-
dervalued, and in particular that attributed during spinoff formation. 
Perhaps if there were more awareness of the regulatory requirements 
and their implications at an earlier stage, the criticality attributed to 
them in supporting both the spinoff venture formation and the sub-
sequent success and survival may be higher?
Influence of early incorporation of regulations
Although regulatory requirements are often intended to be first con-
sidered during the early stages of academic research, they are more 
likely to only be appropriately considered during later stages. Over 
70% of respondents from both groups I and II strongly agree that the 
early incorporation of regulatory strategies within funding applica-
tions would enhance the funding process. However, whilst funding 
agencies are conscious of the regulatory needs it only becomes a criti-
cal factor in the case of applied research. The funding required to con-
duct such applied research can be heavily influenced by the specific 
regulatory requirements of the medical device, particularly those of 
the required pre-clinical and animal testing and potential necessity to 
conduct clinical investigations. Incorporating these requirements at 
this stage not only gives a better estimate of the required funding and 
anticipated research duration but also allows for both pre-clinical and 
clinical work to be conducted within the requirements of the legisla-
tion. This latter point has been demonstrated by the Investigational 
Assistance Program (IAP) at the University of Minnesota’s Academic 
Health Center (AHC) (Arbit and Paller, 2006). Prior to the establis-
hment of the program 24 pre-existing clinical studies were being 
conducted; only 5 were shown to meet the required regulatory obli-
gations. Subsequent to the establishment of the IAP, 20 new clinical 
studies commenced bringing the total number of active studies to 44; 
all of which were shown to be compliant with the regulations and, in 
some cases, the amount of research time saved amounted to one year.
The early incorporation of regulatory strategies within a business plan 
would enhance the spinoff process. Muller (2010) observes having 
complementary skills reduces the time-lag in the establishment of an 
academic spinoff firm supported by Grimaldi et al. (2011) who no-
tes that one of the primary challenges in the evolution of technology 
transfer is that of identifying suitable actors to bridge the academic 
and commercial divide. In the medical device industry, this particu-
larly concerns regulatory requirements which rapidly increase as a 
medical device approaches market entry. The suggestion of the earlier 
incorporation of regulatory strategies to support spinoff formation is 
further supported by Curran et al. (2011) who note that it may be 
prudent to include people with strong industry knowledge (i.e. regu-
latory knowledge) in the management team of university spin-offs at 
the earliest possible stage. 
Venture capitalists prefer to invest after the seed stage once ventures 
have become established and are likely to have already demonstrated 
regulatory compliance where regulatory considerations may not be a 
significant contributor to investment decisions (Wright et al., 2006). 
It appears the decision to invest is largely focused on factors which 
directly contribute to return on investment such as IP protection and 
market opportunity. In the case of ventures seeking seed or start-up 
capital the influence of regulatory considerations on investment de-
cisions are liable to increase. The benefits of addressing regulatory re-
quirement at an early stage can be seen to be dependent on the type 
of capital being sought: seed, start up, early stage, expansion stage or 
late stage.
Conclusions
Our findings reveal is that there is an apparent degree of se-
paration between the academic spinoff formation process and 
the regulatory process, with the regulatory process lagging that 
of the spinoff process.  Whilst the medical device regulatory 
framework may not prevent a spinoff from forming, it cer-
tainly has the potential to delay, perhaps significantly, mar-
ket entry. To temper this, these two processes should be seen 
to work in parallel from the earliest stage of the commercia-
lisation process. Furthermore, given the nuances of the me-
dical device regulatory framework, expert regulatory input is 
J. Technol. Manag. Innov. 2019. Volume 14, Issue 3
ISSN: 0718-2724. (http://jotmi.org)
Journal of Technology Management & Innovation © Universidad Alberto Hurtado, Facultad de Economía y Negocios. 89
highly recommended to be sought at this early stage. Such an 
approach can be seen to significantly support the spinoff process 
across several stages:
• Funding: both the duration and resources required to com-
mercialise medical device research are heavily influenced 
by the specific regulatory requirements of the concerned te-
chnology. A better commercial case for the medical device, 
based on more accurate estimates of duration and cost, resul-
ting from a sound understanding of regulatory requirements 
would be provided for.
• Research Activities: conducting pre-clinical testing in line 
with relevant standards reduces the burden of demonstra-
ting conformance to the relevant medical device legislation. 
This is a long term benefit which pre-empts the regulatory 
requirements which increase substantially as market entry 
approaches.
• Capital Investment: market access is dictated by meeting the 
regulatory requirements. This is particularly pertinent in the 
case of highly innovative medical technologies seeking seed 
or start-up capital. Demonstrating an astute regulatory stra-
tegy corroborates market access strategies.
A key aspect of this is the establishment of a micro enterprise sup-
port structure should be established to support indigenous start-
ups at third level.  To foster and support spinoff creation within the 
medical device sector it is essential that this structure incorporates 
a regulatory support mechanism. Such a support mechanism may 
become a necessity should the proposed new medical device re-
gulations come into force as currently proposed as there will be a 
requirement for manufacturers to have available within their orga-
nisation a person responsible for regulatory compliance activities 
who possesses expert knowledge in the field of medical devices. In 
the case of micro and small enterprises, whilst they are not requi-
red to have such expertise within their organisation they will be 
required to have such person permanently and continuously at their 
disposal.
Our analysis makes important contributions to technology manage-
ment research. Our findings provide an insight into the impact of 
medical device regulations on academic spinoff formation across 
a wide and diverse range of stakeholders. Prior research recogni-
zes that regulations are essential to commercialisation success and 
our findings add to this debate. These results allow us to advance 
the general theoretical development of the field. These findings are 
useful in furthering our understanding of how to best bridge the 
gap between theory and practice. Hence, this study is of managerial 
relevance to entrepreneurs. Certain limitations of this study should 
be noted. This study focused solely on academic spinoffs operating 
in the medical technology industry in a small open economy i.e. Ire-
land. Consequently, the context of this study is quite specific, and the 
explanatory power of our findings may be limited to this particular 
industry or country. Future studies could strive to address this deficit.
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